ArticlePediatric hematology and oncology2022

Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.

Stephanie M Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.